JP2019532644A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019532644A5 JP2019532644A5 JP2019517305A JP2019517305A JP2019532644A5 JP 2019532644 A5 JP2019532644 A5 JP 2019532644A5 JP 2019517305 A JP2019517305 A JP 2019517305A JP 2019517305 A JP2019517305 A JP 2019517305A JP 2019532644 A5 JP2019532644 A5 JP 2019532644A5
- Authority
- JP
- Japan
- Prior art keywords
- casx
- seq
- nucleic acid
- polypeptide
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022199477A JP2023027277A (ja) | 2016-09-30 | 2022-12-14 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
| JP2025133612A JP2025166123A (ja) | 2016-09-30 | 2025-08-08 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662402846P | 2016-09-30 | 2016-09-30 | |
| US62/402,846 | 2016-09-30 | ||
| PCT/US2017/054081 WO2018064371A1 (en) | 2016-09-30 | 2017-09-28 | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199477A Division JP2023027277A (ja) | 2016-09-30 | 2022-12-14 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019532644A JP2019532644A (ja) | 2019-11-14 |
| JP2019532644A5 true JP2019532644A5 (enExample) | 2020-11-12 |
Family
ID=61760962
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517305A Pending JP2019532644A (ja) | 2016-09-30 | 2017-09-28 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
| JP2022199477A Pending JP2023027277A (ja) | 2016-09-30 | 2022-12-14 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
| JP2025133612A Pending JP2025166123A (ja) | 2016-09-30 | 2025-08-08 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199477A Pending JP2023027277A (ja) | 2016-09-30 | 2022-12-14 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
| JP2025133612A Pending JP2025166123A (ja) | 2016-09-30 | 2025-08-08 | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US11873504B2 (enExample) |
| EP (1) | EP3523426A4 (enExample) |
| JP (3) | JP2019532644A (enExample) |
| KR (2) | KR20230170126A (enExample) |
| CN (1) | CN110023494A (enExample) |
| AU (1) | AU2017335890B2 (enExample) |
| BR (1) | BR112019006384A2 (enExample) |
| CA (1) | CA3038960A1 (enExample) |
| EA (1) | EA201990861A1 (enExample) |
| GB (1) | GB2569733B (enExample) |
| IL (1) | IL265598A (enExample) |
| MX (1) | MX2019003674A (enExample) |
| NZ (1) | NZ751946A (enExample) |
| WO (1) | WO2018064371A1 (enExample) |
Families Citing this family (105)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| US11053481B2 (en) | 2013-12-12 | 2021-07-06 | President And Fellows Of Harvard College | Fusions of Cas9 domains and nucleic acid-editing domains |
| EP4079847A1 (en) | 2014-07-30 | 2022-10-26 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| EP3204496A1 (en) | 2014-10-10 | 2017-08-16 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| WO2016073990A2 (en) | 2014-11-07 | 2016-05-12 | Editas Medicine, Inc. | Methods for improving crispr/cas-mediated genome-editing |
| JP7030522B2 (ja) | 2015-05-11 | 2022-03-07 | エディタス・メディシン、インコーポレイテッド | 幹細胞における遺伝子編集のための最適化ｃｒｉｓｐｒ／ｃａｓ９システムおよび方法 |
| EP3919622A1 (en) | 2015-06-01 | 2021-12-08 | Temple University - Of The Commonwealth System of Higher Education | Methods and compositions for rna-guided treatment of hiv infection |
| JP7396783B2 (ja) | 2015-06-09 | 2023-12-12 | エディタス・メディシン、インコーポレイテッド | 移植を改善するためのｃｒｉｓｐｒ／ｃａｓ関連方法および組成物 |
| AU2016326711B2 (en) | 2015-09-24 | 2022-11-03 | Editas Medicine, Inc. | Use of exonucleases to improve CRISPR/Cas-mediated genome editing |
| IL294014B2 (en) | 2015-10-23 | 2024-07-01 | Harvard College | Nucleobase editors and uses thereof |
| EP3433363A1 (en) | 2016-03-25 | 2019-01-30 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
| WO2017180694A1 (en) | 2016-04-13 | 2017-10-19 | Editas Medicine, Inc. | Cas9 fusion molecules gene editing systems, and methods of use thereof |
| US10337051B2 (en) | 2016-06-16 | 2019-07-02 | The Regents Of The University Of California | Methods and compositions for detecting a target RNA |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| CA3038982A1 (en) | 2016-09-30 | 2018-04-05 | The Regents Of The University Of California | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
| WO2018064371A1 (en) | 2016-09-30 | 2018-04-05 | The Regents Of The University Of California | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
| SG11201903089RA (en) | 2016-10-14 | 2019-05-30 | Harvard College | Aav delivery of nucleobase editors |
| WO2018119010A1 (en) | 2016-12-19 | 2018-06-28 | Editas Medicine, Inc. | Assessing nuclease cleavage |
| US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
| EP4095263A1 (en) | 2017-01-06 | 2022-11-30 | Editas Medicine, Inc. | Methods of assessing nuclease cleavage |
| JP2020513783A (ja) * | 2017-01-18 | 2020-05-21 | エクシジョン バイオセラピューティクス インコーポレイテッド | Ｃｒｉｓｐｒ |
| US20190367924A1 (en) * | 2017-02-17 | 2019-12-05 | Temple University - Of The Commonwealth System Of Higher Education | Gene editing therapy for hiv infection via dual targeting of hiv genome and ccr5 |
| EP3592381A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Cancer vaccine |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| GB2575930A (en) | 2017-03-23 | 2020-01-29 | Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
| WO2018201086A1 (en) | 2017-04-28 | 2018-11-01 | Editas Medicine, Inc. | Methods and systems for analyzing guide rna molecules |
| WO2018202800A1 (en) * | 2017-05-03 | 2018-11-08 | Kws Saat Se | Use of crispr-cas endonucleases for plant genome engineering |
| WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
| AU2018279829B2 (en) | 2017-06-09 | 2024-01-04 | Editas Medicine, Inc. | Engineered Cas9 nucleases |
| WO2019014564A1 (en) | 2017-07-14 | 2019-01-17 | Editas Medicine, Inc. | SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES |
| US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| WO2019079347A1 (en) | 2017-10-16 | 2019-04-25 | The Broad Institute, Inc. | USES OF BASIC EDITORS ADENOSINE |
| EP3701013A4 (en) * | 2017-10-25 | 2021-08-04 | Monsanto Technology LLC | TARGETED ENDONUCLEASE ACTIVITY OF RNA-GUIDED ENDONUCLEASE CASX IN EUKARYONTS |
| US12227753B2 (en) | 2017-11-01 | 2025-02-18 | The Regents Of The University Of California | CasY compositions and methods of use |
| EP3704239A4 (en) | 2017-11-01 | 2021-08-18 | The Regents of The University of California | CASZ COMPOSITIONS AND METHODS OF USE |
| WO2019089808A1 (en) | 2017-11-01 | 2019-05-09 | The Regents Of The University Of California | Class 2 crispr/cas compositions and methods of use |
| US11661599B1 (en) | 2017-12-14 | 2023-05-30 | National Technology & Engineering Solutions Of Sandia, Llc | CRISPR-Cas based system for targeting single-stranded sequences |
| WO2019118949A1 (en) | 2017-12-15 | 2019-06-20 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US20220010293A1 (en) | 2018-02-23 | 2022-01-13 | Pioneer Hi-Bred International, Inc. | Novel cas9 orthologs |
| US11807877B1 (en) | 2018-03-22 | 2023-11-07 | National Technology & Engineering Solutions Of Sandia, Llc | CRISPR/Cas activity assays and compositions thereof |
| WO2019226953A1 (en) | 2018-05-23 | 2019-11-28 | The Broad Institute, Inc. | Base editors and uses thereof |
| AU2019282812B2 (en) | 2018-06-07 | 2025-08-14 | Arc Bio, Llc | Compositions and methods for making guide nucleic acids |
| US20190390193A1 (en) * | 2018-06-23 | 2019-12-26 | John Lawrence Mee | Reversible method for sustainable human cognitive enhancement |
| AU2019291918B2 (en) | 2018-06-29 | 2025-06-12 | Editas Medicine, Inc. | Synthetic guide molecules, compositions and methods relating thereto |
| US20210284981A1 (en) * | 2018-07-24 | 2021-09-16 | The Regents Of The University Of California | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
| WO2020028729A1 (en) | 2018-08-01 | 2020-02-06 | Mammoth Biosciences, Inc. | Programmable nuclease compositions and methods of use thereof |
| US12275964B2 (en) * | 2018-08-22 | 2025-04-15 | The Regents Of The University Of California | Variant type V CRISPR/Cas effector polypeptides and methods of use thereof |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| CN113166744B (zh) | 2018-12-14 | 2025-02-07 | 先锋国际良种公司 | 用于基因组编辑的新颖crispr-cas系统 |
| EP3931313A2 (en) | 2019-01-04 | 2022-01-05 | Mammoth Biosciences, Inc. | Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection |
| AU2020208346A1 (en) * | 2019-01-14 | 2021-07-29 | University Of Rochester | Targeted nuclear RNA cleavage and polyadenylation with CRISPR-cas |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| EP3935156A4 (en) | 2019-03-07 | 2022-12-28 | The Regents of The University of California | CRISPR-CAS EFFECTIVE POLYPEPTIDES AND METHODS OF USE THEREOF |
| CN113825834A (zh) | 2019-03-11 | 2021-12-21 | 索伦托药业有限公司 | 使用rna引导的核酸内切酶进行dna构建体整合的改进工艺 |
| DE112020001342T5 (de) | 2019-03-19 | 2022-01-13 | President and Fellows of Harvard College | Verfahren und Zusammensetzungen zum Editing von Nukleotidsequenzen |
| WO2020206072A1 (en) * | 2019-04-03 | 2020-10-08 | University Of Georgia Research Foundation, Inc. | Delivery of crispr/mcas9 through extracellular vesicles for genome editing |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| GB2600274B (en) * | 2019-06-07 | 2024-11-27 | Scribe Therapeutics Inc | Engineered CasX systems |
| CN114341361B (zh) * | 2019-06-10 | 2024-11-12 | 传染病研究所 | 星状病毒复制子的方法和组合物 |
| WO2021007563A1 (en) * | 2019-07-11 | 2021-01-14 | Arbor Biotechnologies, Inc. | Novel crispr dna targeting enzymes and systems |
| JP7630904B2 (ja) * | 2019-07-23 | 2025-02-18 | 株式会社東芝 | 核酸導入キャリア、核酸導入キャリアセット、核酸導入組成物及び核酸導入方法 |
| WO2021050593A1 (en) * | 2019-09-09 | 2021-03-18 | Scribe Therapeutics Inc. | Compositions and methods for the targeting of sod1 |
| EP4028523A1 (en) * | 2019-09-09 | 2022-07-20 | Scribe Therapeutics Inc. | Compositions and methods for use in immunotherapy |
| WO2021072328A1 (en) | 2019-10-10 | 2021-04-15 | The Broad Institute, Inc. | Methods and compositions for prime editing rna |
| CA3157707A1 (en) * | 2019-10-17 | 2021-04-22 | Pairwise Plants Services, Inc. | Variants of cas12a nucleases and methods of making and use thereof |
| CN110669795A (zh) * | 2019-10-18 | 2020-01-10 | 福州大学 | 一种在鱼类胚胎中实现精确定点rna剪切的技术 |
| JP2023504536A (ja) | 2019-12-06 | 2023-02-03 | スクライブ・セラピューティクス・インコーポレイテッド | 粒子送達システム |
| EP4069845A1 (en) * | 2019-12-06 | 2022-10-12 | Scribe Therapeutics Inc. | Compositions and methods for the targeting of rhodopsin |
| EP4069846A1 (en) | 2019-12-07 | 2022-10-12 | Scribe Therapeutics Inc. | Compositions and methods for the targeting of htt |
| MX2022007858A (es) * | 2019-12-23 | 2022-09-19 | Univ California | Polipeptidos efectores crispr-cas y metodos de uso de estos. |
| BR112022012853A2 (pt) * | 2019-12-30 | 2022-09-20 | Dsm Ip Assets Bv | Cepa modificada por lipase |
| JP2023510352A (ja) * | 2020-01-10 | 2023-03-13 | スクライブ・セラピューティクス・インコーポレイテッド | Ｐｃｓｋ９の標的化のための組成物および方法 |
| CA3167684A1 (en) * | 2020-01-29 | 2021-08-05 | Jenthera Therapeutics Inc. | Nuclease-scaffold composition delivery platform |
| WO2021173612A1 (en) | 2020-02-26 | 2021-09-02 | Sorrento Therapeutics, Inc. | Activatable antigen binding proteins with universal masking moieties |
| EP4114173A1 (en) * | 2020-03-04 | 2023-01-11 | Regeneron Pharmaceuticals, Inc. | A rodent model of b4galt1-mediated functions |
| JP7755837B2 (ja) * | 2020-03-12 | 2025-10-17 | 学校法人福岡大学 | オリゴヌクレオチド及び標的ｒｎａの部位特異的編集方法 |
| EP4121535A1 (en) * | 2020-03-18 | 2023-01-25 | Scribe Therapeutics Inc. | Compositions and methods for the targeting of c9orf72 |
| WO2021217083A1 (en) | 2020-04-24 | 2021-10-28 | Sorrento Therapeutics, Inc. | Memory dimeric antigen receptors |
| GB2614813B (en) | 2020-05-08 | 2025-05-07 | Harvard College | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| KR20230058624A (ko) * | 2020-07-30 | 2023-05-03 | 아다르엑스 파마슈티컬스, 인크. | Adar 의존성 편집 조성물 및 그의 사용 방법 |
| EP4244343A4 (en) | 2020-11-11 | 2025-05-07 | Monsanto Technology LLC | PROCEDURES FOR IMPROVING SITE-SPECIFIC INTEGRATION FREQUENCY |
| WO2022119957A1 (en) * | 2020-12-02 | 2022-06-09 | The Regents Of The University Of California | Crispr-cas effector polypeptides and methods of use thereof |
| EP4256054A1 (en) * | 2020-12-03 | 2023-10-11 | Scribe Therapeutics Inc. | Engineered class 2 type v crispr systems |
| WO2022120089A1 (en) * | 2020-12-03 | 2022-06-09 | Scribe Therapeutics Inc. | Compositions and methods for the targeting of ptbp1 |
| IL303498A (en) * | 2020-12-09 | 2023-08-01 | Scribe Therapeutics Inc | Aav vectors for gene editing |
| EP4267743A4 (en) | 2020-12-22 | 2024-12-18 | Chroma Medicine, Inc. | Compositions and methods for epigenetic editing |
| TW202313971A (zh) | 2021-06-01 | 2023-04-01 | 美商喬木生物技術公司 | 包含crispr核酸酶的基因編輯系統及其用途 |
| WO2022261150A2 (en) | 2021-06-09 | 2022-12-15 | Scribe Therapeutics Inc. | Particle delivery systems |
| WO2023049742A2 (en) * | 2021-09-21 | 2023-03-30 | Scribe Therapeutics Inc. | Engineered casx repressor systems |
| CN113969281B (zh) * | 2021-12-24 | 2022-04-01 | 汕头大学 | 经修饰的CrRNA片段及非洲猪瘟病毒试剂盒 |
| IL322416A (en) | 2023-02-15 | 2025-09-01 | Arbor Biotechnologies Inc | Gene editing method to inhibit abnormal splicing in stathmin 2 (stmn2) transcription |
| TW202444914A (zh) * | 2023-03-29 | 2024-11-16 | 美商斯奎柏治療公司 | 抑制子融合蛋白系統 |
| CN116926043B (zh) * | 2023-04-28 | 2024-09-06 | 新乡医学院第三附属医院 | 一种dCasX蛋白核酸酶、重组载体及其应用 |
| WO2024233366A2 (en) * | 2023-05-05 | 2024-11-14 | Aera Therapeutics, Inc. | Modified cas9-iid nucleases and uses thereof |
| WO2025171210A1 (en) | 2024-02-09 | 2025-08-14 | Arbor Biotechnologies, Inc. | Compositions and methods for gene editing via homology-mediated end joining |
| CN119709771B (zh) * | 2024-10-24 | 2025-11-25 | 四川轻化工大学 | 马铃薯drm3基因及其在马铃薯保鲜中的应用 |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| AU2001263449A1 (en) | 2000-05-24 | 2001-12-03 | Third Wave Technologies, Inc | Detection of RNA |
| US6773885B1 (en) | 2000-09-29 | 2004-08-10 | Integrated Dna Technologies, Inc. | Compositions and methods for visual ribonuclease detection assays |
| CN1886512A (zh) * | 2002-04-23 | 2006-12-27 | 斯克里普斯研究所 | 多肽在叶绿体中的表达以及用于表达多肽的组合物和方法 |
| EP1580273A1 (en) | 2004-03-26 | 2005-09-28 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Peptide-based method for monitoring gene expression in a host cell |
| ZA200803368B (en) | 2005-10-07 | 2009-09-30 | Univ California | Nucleic acids encoding modified cytochrome P450 enzymes and methods of use thereof |
| US9689031B2 (en) | 2007-07-14 | 2017-06-27 | Ionian Technologies, Inc. | Nicking and extension amplification reaction for the exponential amplification of nucleic acids |
| WO2010075303A1 (en) | 2008-12-23 | 2010-07-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same |
| CA2790123A1 (en) | 2010-02-15 | 2011-08-18 | Cascade Biosystems, Inc. | Methods and materials for detecting viral or microbial infections |
| JP2013531983A (ja) | 2010-06-11 | 2013-08-15 | パソジェニカ，インコーポレイテッド | 多重生物検出のための核酸ならびにその使用および製造方法 |
| US9193827B2 (en) | 2010-08-26 | 2015-11-24 | Massachusetts Institute Of Technology | Poly(beta-amino alcohols), their preparation, and uses thereof |
| US9580714B2 (en) | 2010-11-24 | 2017-02-28 | The University Of Western Australia | Peptides for the specific binding of RNA targets |
| US9730967B2 (en) | 2011-02-04 | 2017-08-15 | Katherine Rose Kovarik | Method and system for treating cancer cachexia |
| US8815782B2 (en) | 2011-11-11 | 2014-08-26 | Agilent Technologies, Inc. | Use of DNAzymes for analysis of an RNA sample |
| WO2013155555A1 (en) | 2012-04-16 | 2013-10-24 | The University Of Western Australia | Peptides for the binding of nucleotide targets |
| WO2013176772A1 (en) * | 2012-05-25 | 2013-11-28 | The Regents Of The University Of California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| ES2713243T3 (es) | 2012-12-06 | 2019-05-20 | Sigma Aldrich Co Llc | Modificación y regulación del genoma basada en CRISPR |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| AU2013359199C1 (en) | 2012-12-12 | 2021-06-17 | Massachusetts Institute Of Technology | Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications |
| US20140310830A1 (en) | 2012-12-12 | 2014-10-16 | Feng Zhang | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes |
| EP4234696A3 (en) | 2012-12-12 | 2023-09-06 | The Broad Institute Inc. | Crispr-cas component systems, methods and compositions for sequence manipulation |
| IL307735A (en) | 2012-12-12 | 2023-12-01 | Broad Inst Inc | Systems engineering, methods and optimal guiding components for sequence manipulation |
| WO2014093701A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof |
| DK2921557T3 (en) | 2012-12-12 | 2016-11-07 | Broad Inst Inc | Design of systems, methods and optimized sequence manipulation guide compositions |
| PL2931898T3 (pl) | 2012-12-12 | 2016-09-30 | Le Cong | Projektowanie i optymalizacja systemów, sposoby i kompozycje do manipulacji sekwencją z domenami funkcjonalnymi |
| CN105209621B (zh) | 2012-12-12 | 2021-05-25 | 布罗德研究所有限公司 | 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化 |
| BR102013032129B1 (pt) | 2012-12-13 | 2022-06-07 | Dow Agrosciences Llc | Método para identificar a presença de um polinucleotídeo de dna doador exógeno inserido dentro de um único locus genômico eucariótico alvo |
| EP4481048A3 (en) | 2012-12-17 | 2025-02-26 | President and Fellows of Harvard College | Rna-guided human genome engineering |
| WO2014118272A1 (en) | 2013-01-30 | 2014-08-07 | Santaris Pharma A/S | Antimir-122 oligonucleotide carbohydrate conjugates |
| US10227610B2 (en) | 2013-02-25 | 2019-03-12 | Sangamo Therapeutics, Inc. | Methods and compositions for enhancing nuclease-mediated gene disruption |
| ES2901396T3 (es) | 2013-03-14 | 2022-03-22 | Caribou Biosciences Inc | Composiciones y métodos de ácidos nucleicos dirigidos a ácido nucleico |
| US11332719B2 (en) | 2013-03-15 | 2022-05-17 | The Broad Institute, Inc. | Recombinant virus and preparations thereof |
| US20140273230A1 (en) | 2013-03-15 | 2014-09-18 | Sigma-Aldrich Co., Llc | Crispr-based genome modification and regulation |
| AU2014228981B2 (en) | 2013-03-15 | 2019-11-28 | The General Hospital Corporation | Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing |
| US20140349400A1 (en) | 2013-03-15 | 2014-11-27 | Massachusetts Institute Of Technology | Programmable Modification of DNA |
| US9234213B2 (en) | 2013-03-15 | 2016-01-12 | System Biosciences, Llc | Compositions and methods directed to CRISPR/Cas genomic engineering systems |
| US20140364333A1 (en) | 2013-03-15 | 2014-12-11 | President And Fellows Of Harvard College | Methods for Live Imaging of Cells |
| US10760064B2 (en) | 2013-03-15 | 2020-09-01 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
| WO2014144155A1 (en) | 2013-03-15 | 2014-09-18 | Regents Of The University Of Minnesota | Engineering plant genomes using crispr/cas systems |
| AU2014248208C1 (en) | 2013-04-05 | 2023-04-27 | Corteva Agriscience Llc | Methods and compositions for integration of an exogenous sequence within the genome of plants |
| SI2986729T1 (sl) | 2013-04-16 | 2019-02-28 | Regeneron Pharmaceuticals, Inc. | Ciljana sprememba genoma podgane |
| AU2014262867B2 (en) | 2013-05-10 | 2019-12-05 | Sangamo Therapeutics, Inc. | Delivery methods and compositions for nuclease-mediated genome engineering |
| CA2913234A1 (en) | 2013-05-22 | 2014-11-27 | Northwestern University | Rna-directed dna cleavage and gene editing by cas9 enzyme from neisseria meningitidis |
| US9873907B2 (en) | 2013-05-29 | 2018-01-23 | Agilent Technologies, Inc. | Method for fragmenting genomic DNA using CAS9 |
| US20140356956A1 (en) | 2013-06-04 | 2014-12-04 | President And Fellows Of Harvard College | RNA-Guided Transcriptional Regulation |
| EP3071695A2 (en) * | 2013-11-18 | 2016-09-28 | Crispr Therapeutics AG | Crispr-cas system materials and methods |
| US9994831B2 (en) | 2013-12-12 | 2018-06-12 | The Regents Of The University Of California | Methods and compositions for modifying a single stranded target nucleic acid |
| US9850525B2 (en) | 2014-01-29 | 2017-12-26 | Agilent Technologies, Inc. | CAS9-based isothermal method of detection of specific DNA sequence |
| EP3126498A4 (en) | 2014-03-20 | 2017-08-23 | Université Laval | Crispr-based methods and products for increasing frataxin levels and uses thereof |
| EP3129488B1 (en) | 2014-04-10 | 2019-06-12 | The Regents of The University of California | Methods and compositions for using argonaute to modify a single stranded target nucleic acid |
| CA2951707A1 (en) | 2014-06-10 | 2015-12-17 | Massachusetts Institute Of Technology | Method for gene editing |
| WO2016028843A2 (en) | 2014-08-19 | 2016-02-25 | President And Fellows Of Harvard College | Rna-guided systems for probing and mapping of nucleic acids |
| EP3985115A1 (en) | 2014-12-12 | 2022-04-20 | The Broad Institute, Inc. | Protected guide rnas (pgrnas) |
| WO2016094872A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Dead guides for crispr transcription factors |
| WO2016106236A1 (en) | 2014-12-23 | 2016-06-30 | The Broad Institute Inc. | Rna-targeting system |
| WO2016123243A1 (en) * | 2015-01-28 | 2016-08-04 | The Regents Of The University Of California | Methods and compositions for labeling a single-stranded target nucleic acid |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| CA3012631A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| MX392008B (es) | 2015-06-18 | 2025-03-21 | Broad Inst Inc | Mutaciones de la enzima crispr que reducen los efectos fuera del blanco |
| EP3436575A1 (en) | 2015-06-18 | 2019-02-06 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| US9580727B1 (en) | 2015-08-07 | 2017-02-28 | Caribou Biosciences, Inc. | Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides |
| US12234454B2 (en) | 2015-10-22 | 2025-02-25 | The Broad Institute, Inc. | Crispr enzymes and systems |
| US11193127B2 (en) | 2016-01-08 | 2021-12-07 | University Of Georgia Research Foundation, Inc. | Methods for cleaving DNA and RNA molecules |
| US11441146B2 (en) | 2016-01-11 | 2022-09-13 | Christiana Care Health Services, Inc. | Compositions and methods for improving homogeneity of DNA generated using a CRISPR/Cas9 cleavage system |
| US9896696B2 (en) * | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
| CN109312336A (zh) | 2016-02-23 | 2019-02-05 | 阿克生物公司 | 用于靶标检测的方法和组合物 |
| US20190093091A1 (en) | 2016-04-06 | 2019-03-28 | Temple University - Of The Commonwealth System Of Higher Education | Compositions for eradicating flavivirus infections in subjects |
| US11371081B2 (en) | 2016-05-25 | 2022-06-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Portable, low-cost pathogen detection and strain identification platform |
| US10337051B2 (en) | 2016-06-16 | 2019-07-02 | The Regents Of The University Of California | Methods and compositions for detecting a target RNA |
| AU2017283713B2 (en) | 2016-06-17 | 2021-04-08 | Massachusetts Institute Of Technology | Type VI CRISPR orthologs and systems |
| DK3474669T3 (da) * | 2016-06-24 | 2022-06-27 | Univ Colorado Regents | Fremgangsmåde til generering af stregkodede kombinatoriske biblioteker |
| US12431216B2 (en) | 2016-08-17 | 2025-09-30 | Broad Institute, Inc. | Methods for identifying class 2 crispr-cas systems |
| CA3038982A1 (en) | 2016-09-30 | 2018-04-05 | The Regents Of The University Of California | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
| WO2018064371A1 (en) | 2016-09-30 | 2018-04-05 | The Regents Of The University Of California | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
| CN106701830B (zh) | 2016-12-07 | 2020-01-03 | 湖南人文科技学院 | 一种敲除猪胚胎p66shc基因的方法 |
| EP4119663B1 (en) | 2016-12-09 | 2024-11-27 | The Broad Institute, Inc. | Crispr effector system based diagnostics |
| KR102842382B1 (ko) | 2017-03-24 | 2025-08-04 | 큐어백 에스이 | Crispr-연관 단백질을 암호화하는 핵산 및 이의 용도 |
| AU2018254619B2 (en) | 2017-04-21 | 2022-07-21 | The General Hospital Corporation | Variants of Cpf1 (CAS12a) with altered PAM specificity |
| EP4407034A3 (en) | 2017-08-09 | 2024-10-30 | RiceTec, Inc. | Compositions and methods for modifying genomes |
| WO2019089808A1 (en) | 2017-11-01 | 2019-05-09 | The Regents Of The University Of California | Class 2 crispr/cas compositions and methods of use |
| US12227753B2 (en) | 2017-11-01 | 2025-02-18 | The Regents Of The University Of California | CasY compositions and methods of use |
| EP3704239A4 (en) | 2017-11-01 | 2021-08-18 | The Regents of The University of California | CASZ COMPOSITIONS AND METHODS OF USE |
| WO2019089796A1 (en) | 2017-11-01 | 2019-05-09 | The Regents Of The University Of California | Cas12c compositions and methods of use |
| US10253365B1 (en) | 2017-11-22 | 2019-04-09 | The Regents Of The University Of California | Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs |
| WO2019126577A2 (en) | 2017-12-22 | 2019-06-27 | The Broad Institute, Inc. | Crispr effector system based multiplex diagnostics |
-
2017
- 2017-09-28 WO PCT/US2017/054081 patent/WO2018064371A1/en not_active Ceased
- 2017-09-28 CN CN201780074116.1A patent/CN110023494A/zh active Pending
- 2017-09-28 BR BR112019006384-6A patent/BR112019006384A2/pt not_active Application Discontinuation
- 2017-09-28 CA CA3038960A patent/CA3038960A1/en active Pending
- 2017-09-28 NZ NZ751946A patent/NZ751946A/en unknown
- 2017-09-28 US US16/335,516 patent/US11873504B2/en active Active
- 2017-09-28 GB GB1905575.5A patent/GB2569733B/en active Active
- 2017-09-28 MX MX2019003674A patent/MX2019003674A/es unknown
- 2017-09-28 EP EP17857442.2A patent/EP3523426A4/en active Pending
- 2017-09-28 KR KR1020237041555A patent/KR20230170126A/ko not_active Ceased
- 2017-09-28 AU AU2017335890A patent/AU2017335890B2/en active Active
- 2017-09-28 JP JP2019517305A patent/JP2019532644A/ja active Pending
- 2017-09-28 EA EA201990861A patent/EA201990861A1/ru unknown
- 2017-09-28 KR KR1020197012244A patent/KR20190071725A/ko not_active Ceased
-
2018
- 2018-08-03 US US16/054,513 patent/US10570415B2/en active Active
-
2019
- 2019-03-25 IL IL265598A patent/IL265598A/en unknown
- 2019-05-24 US US16/422,824 patent/US11795472B2/en active Active
-
2022
- 2022-12-14 JP JP2022199477A patent/JP2023027277A/ja active Pending
-
2023
- 2023-11-17 US US18/513,347 patent/US20240167052A1/en active Pending
-
2025
- 2025-08-08 JP JP2025133612A patent/JP2025166123A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019532644A5 (enExample) | ||
| JP2019534695A5 (enExample) | ||
| JP2021121205A5 (enExample) | ||
| JP7154248B2 (ja) | 標的遺伝子座を修飾するための方法及び組成物 | |
| CN111328343B (zh) | Rna靶向方法和组合物 | |
| JP7095066B2 (ja) | 単一ステップの複数標的化を通じた標的化された遺伝子修飾のための方法及び組成物 | |
| US11591589B2 (en) | Variants of Cpf1 (Cas12a) with altered PAM specificity | |
| JP2024095765A (ja) | Ｓ．ピオゲネスｃａｓ９変異遺伝子及びこれによってコードされるポリペプチド | |
| JP2015503535A5 (enExample) | ||
| US9567603B2 (en) | Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing | |
| US9840699B2 (en) | Methods for nucleic acid editing | |
| KR20190025565A (ko) | 프로그램가능한 dna 결합 단백질을 사용한, 표적화된 게놈 변형의 개선 | |
| AU2016297167A1 (en) | Editing mitochondrial DNA | |
| KR20240055073A (ko) | 클래스 ii, v형 crispr 시스템 | |
| Delacôte et al. | High frequency targeted mutagenesis using engineered endonucleases and DNA-end processing enzymes | |
| US11970720B2 (en) | RNA targeting methods and compositions | |
| US8975042B2 (en) | Fluorescent and colored proteins and methods for using them | |
| WO2020077138A2 (en) | Selective curbing of unwanted rna editing (secure) dna base editor variants | |
| Zhang et al. | MTV, an ssDNA protecting complex essential for transposon-based telomere maintenance in Drosophila | |
| WO2024198961A1 (zh) | 一种Cas蛋白及其突变体、其相应的基因编辑系统及应用 | |
| US9771402B2 (en) | Fluorescent and colored proteins and methods for using them | |
| CN112930398A (zh) | 新的核酸酶结构域及其利用 | |
| JPWO2020181102A5 (enExample) | ||
| Wei et al. | Engineering eukaryotic transposon-encoded Fanzor2 system for genome editing in mammals | |
| Zhou et al. | Optical Control of Base Editing and Transcription through Light‐Activated Guide RNA |